Anan Yin

680 total citations
31 papers, 516 citations indexed

About

Anan Yin is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Anan Yin has authored 31 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Genetics and 9 papers in Cancer Research. Recurrent topics in Anan Yin's work include Glioma Diagnosis and Treatment (14 papers), Epigenetics and DNA Methylation (8 papers) and MicroRNA in disease regulation (6 papers). Anan Yin is often cited by papers focused on Glioma Diagnosis and Treatment (14 papers), Epigenetics and DNA Methylation (8 papers) and MicroRNA in disease regulation (6 papers). Anan Yin collaborates with scholars based in China, France and United States. Anan Yin's co-authors include Xiang Zhang, Jinxiang Cheng, Bo-lin Liu, Luhua Zhang, Yu Dong, Li Xm, Yingqi Zhang, Nannan Han, H-Y Huang and Bolin Liu and has published in prestigious journals such as PLoS ONE, Oncogene and BMC Public Health.

In The Last Decade

Anan Yin

30 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anan Yin China 14 266 204 157 110 71 31 516
Yufang Zhu China 13 162 0.6× 117 0.6× 131 0.8× 73 0.7× 70 1.0× 41 518
Kenneth B. Fallon United States 12 159 0.6× 141 0.7× 87 0.6× 85 0.8× 70 1.0× 19 504
Anupam Kumar India 16 270 1.0× 186 0.9× 136 0.9× 65 0.6× 36 0.5× 31 699
Arshad A. Pandith India 14 323 1.2× 87 0.4× 139 0.9× 63 0.6× 35 0.5× 68 604
Yu-Kai Su Taiwan 10 162 0.6× 55 0.3× 85 0.5× 57 0.5× 43 0.6× 14 340
Ravi Medikonda United States 10 138 0.5× 170 0.8× 71 0.5× 74 0.7× 170 2.4× 33 534
Kavneet Kaur India 10 136 0.5× 94 0.5× 53 0.3× 48 0.4× 41 0.6× 39 347
Bin Fu China 14 314 1.2× 163 0.8× 136 0.9× 57 0.5× 53 0.7× 29 647
Gregory N. Adams United States 10 194 0.7× 135 0.7× 55 0.4× 61 0.6× 73 1.0× 15 550
Mariko Takenokuchi Japan 12 317 1.2× 63 0.3× 198 1.3× 38 0.3× 102 1.4× 30 609

Countries citing papers authored by Anan Yin

Since Specialization
Citations

This map shows the geographic impact of Anan Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anan Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anan Yin more than expected).

Fields of papers citing papers by Anan Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anan Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anan Yin. The network helps show where Anan Yin may publish in the future.

Co-authorship network of co-authors of Anan Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Anan Yin. A scholar is included among the top collaborators of Anan Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anan Yin. Anan Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Xiaolin, Xiao Liu, Xiaonan Luo, et al.. (2025). Synergistic strategies for glioblastoma treatment: CRISPR-based multigene editing combined with immune checkpoint blockade. Journal of Nanobiotechnology. 23(1). 94–94. 5 indexed citations
3.
Zou, Cheng, Xiao Liu, Weizhong Wang, et al.. (2025). Targeting GDF15 to enhance immunotherapy efficacy in glioblastoma through tumor microenvironment-responsive CRISPR-Cas9 nanoparticles. Journal of Nanobiotechnology. 23(1). 126–126. 4 indexed citations
4.
Yin, Anan, Feng Zhang, Yalong He, et al.. (2024). Machine learning prediction models for in-hospital postoperative functional outcome after moderate-to-severe traumatic brain injury. European Journal of Trauma and Emergency Surgery. 50(4). 1219–1228. 3 indexed citations
5.
Chi, Maoru, et al.. (2024). FeMOFs/CO loading reduces NETosis and macrophage inflammatory response in PLA based cardiovascular stent materials. Regenerative Biomaterials. 12. rbae140–rbae140. 2 indexed citations
6.
Xie, Rui, Shengrui Zhang, Yuchen Liu, et al.. (2023). Correlation between intraosseous thermal change and drilling impulse data during osteotomy within autonomous dental implant robotic system: An in vitro study. Clinical Oral Implants Research. 35(3). 258–267. 9 indexed citations
7.
8.
Li, Bowen, Jiu Wang, Fangfang Liu, et al.. (2022). A Novel Pseudogene Methylation Signature to Predict Temozolomide Outcome in Non-G-CIMP Glioblastomas. Journal of Oncology. 2022. 1–15. 4 indexed citations
9.
Liu, Fangfang, Bowen Li, Yufeng Wang, et al.. (2022). Neuropathy-associated Fars2 deficiency affects neuronal development and potentiates neuronal apoptosis by impairing mitochondrial function. Cell & Bioscience. 12(1). 103–103. 15 indexed citations
10.
Yin, Anan, et al.. (2020). FAM96A knock-out promotes alternative macrophage polarization and protects mice against sepsis. Clinical & Experimental Immunology. 203(3). 433–447. 10 indexed citations
11.
Yin, Anan, Yalong He, Amandine Etcheverry, et al.. (2019). Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas. Clinical Epigenetics. 11(1). 76–76. 13 indexed citations
12.
Yin, Anan, Amandine Etcheverry, Marc Aubry, et al.. (2018). A novel prognostic six‐CpG signature in glioblastomas. CNS Neuroscience & Therapeutics. 24(3). 167–177. 23 indexed citations
13.
Lin, Wei, Wei Zhang, Anan Yin, et al.. (2016). Dec1 expression predicts prognosis and the response to temozolomide chemotherapy in patients with glioma. Molecular Medicine Reports. 14(6). 5626–5636. 13 indexed citations
14.
Xiong, Wei, et al.. (2015). Resveratrol suppresses human glioblastoma cell migration and invasion via activation of RhoA/ROCK signaling pathway. Oncology Letters. 11(1). 484–490. 23 indexed citations
15.
Yin, Anan, H-Y Huang, Li Xm, et al.. (2014). TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway. Oncogene. 34(5). 600–610. 111 indexed citations
16.
Yin, Anan, Luhua Zhang, Jinxiang Cheng, et al.. (2014). The Predictive but Not Prognostic Value of MGMT Promoter Methylation Status in Elderly Glioblastoma Patients: A Meta-Analysis. PLoS ONE. 9(1). e85102–e85102. 35 indexed citations
17.
Yin, Anan, et al.. (2014). New way to achieve frontal facial photographs of the head in its natural position. British Journal of Oral and Maxillofacial Surgery. 52(6). 563–565. 6 indexed citations
18.
Yin, Anan, Luhua Zhang, Jinxiang Cheng, et al.. (2013). Radiotherapy Plus Concurrent or Sequential Temozolomide for Glioblastoma in the Elderly: A Meta-Analysis. PLoS ONE. 8(9). e74242–e74242. 55 indexed citations
19.
Li, Juan, Haifeng Tang, Yun Zhang, et al.. (2013). Saponin 1 Induces Apoptosis and Suppresses NF-κB-Mediated Survival Signaling in Glioblastoma Multiforme (GBM). PLoS ONE. 8(11). e81258–e81258. 21 indexed citations
20.
Yin, Anan, Jinxiang Cheng, Xiang Zhang, & Bo-lin Liu. (2013). The treatment of glioblastomas: A systematic update on clinical Phase III trials. Critical Reviews in Oncology/Hematology. 87(3). 265–282. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yufang Zhu Breakdown of academic impact, for papers by Kenneth B. Fallon Breakdown of academic impact, for papers by Anupam Kumar Breakdown of academic impact, for papers by Arshad A. Pandith Breakdown of academic impact, for papers by Yu-Kai Su Breakdown of academic impact, for papers by Ravi Medikonda Breakdown of academic impact, for papers by Kavneet Kaur Breakdown of academic impact, for papers by Bin Fu Breakdown of academic impact, for papers by Gregory N. Adams Breakdown of academic impact, for papers by Mariko Takenokuchi
Rankless by CCL
2026